Category Pharmaceuticals and Biotech
Press Release
INNOPOLIS K-Startup Showcase Bridges Korean Deep-Tech and U.S. Venture Capital
Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, quantum technology, semiconductors, mobility, and solar panel recycling solution. Read More
Press Release
Peek Healthcare Technologies, Inc. ('Peek') Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar)
PeekDirect™ Delivers Transparent and Affordable Pricing for Brand and Specialty Drugs to Reduce Prescription Costs for Employers and Patients Read More
Press Release
DistillerSR Launches First-of-Its-Kind Agentic AI Capabilities to Eliminate Evidence Silos and Accelerate Time to Market
New Capabilities Place Peer-reviewed Literature Review Evidence at the Fingertips of Research and Commercial Teams to Align Decision-making and Improve Productivity Read More
Press Release
Longwood Healthcare Leaders to Host Boston CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders
Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum Read More
Press Release
PharmaNest, NIH and VCU Launch Confirmatory Retrospective Outcome Study With 1,765 Patients to Advance AI-Driven Digital Pathology in MASLD
PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort) Read More
Press Release
PillSafe Launches SAFE Investment Opportunity to Advance the First Wireless Smart Prescription Bottle Technology System
Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE investment round and will fund final product development and market validation in compelling use-case. Read More
Press Release
Pace Life Sciences to Hold Free Virtual Webinar Through Outsourced Pharma on USP Guidelines for Extractable and Leachable Manufacturing Risk Assessment
Pace® expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies Read More
Press Release
Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule
Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine can fuse soft capsule + granule into one hard capsule. Read More
Press Release
ISPOR's Oncology and Statistical Methods Special Interest Groups Selects DistillerSR for Joint Systematic Review Project
Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR. Read More
Press Release
Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval
Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships Read More
Press Release
Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model Platform
Sia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs). Read More
Press Release
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe and well-tolerated in healthy elderly volunteers, showing a favourable pharmacokinetic profile and high brain penetration. These findings support the advancement of SUL-238 into further clinical development for Alzheimer's and other neurodegenerative diseases. Read More
Press Release
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action Read More
Press Release
Jeff Clark's Final Vision 2025: Best Tech Stocks to Buy
Jeff Clark's Final Vision 2025 reveals expert-vetted tech stock picks in AI, biotech, and quantum computing-built on proven options strategies, chaos pattern analysis, and actionable investment timelines for serious traders seeking growth in a volatile market. Read More
Press Release
Canary Cure Therapeutics Unveils Breakthrough Human Cell Data for Next-Generation Obesity Therapy, CCT-217, Demonstrating Muscle-Building Fat Loss and Paving Path to Clinic
Dual siRNA Therapeutic Confirms Its Robust In Vivo Results, Strongly De-Risking the Clinical Path and Underscoring CCT-217's Potential as a Transformative, Patient-Friendly Therapy for Obesity and Metabolic Disorders Read More
Press Release
PillSafe Taps Healthcare Veteran Lon G. von Hurwitz to Lead Brand Modernization and Commercial Strategy
Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will guide efforts to bring the smart medication delivery technology to market in early 2026. Read More
Press Release
Valneva Selects CliniOps as the Technology Partner for Multiple Post-Marketing Studies to Support the IXCHIQ Chikungunya Vaccination Program in Brazil
This collaboration underscores CliniOps' continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies. Read More
Press Release
HealthRX Introduces Overnight Access to Ozempic and GLP-1 Medications-No Insurance Needed
HealthRX's direct-access platform eliminates insurance roadblocks by offering overnight delivery of doctor-prescribed GLP-1 weight loss medications like Ozempic® and semaglutide-backed by licensed physicians, transparent pricing, and real results. Read More
Press Release
I-MAK Report Reveals How Extending Patent Terms Inflates Prices of Medicare's Top Negotiated Drugs
Data brief analyzes patenting and pricing practices for blockbuster drugs Eliquis and semaglutide medications (Ozempic, Rybelsus, Wegovy), continuing the acclaimed Overpatented, Overpriced series that exposes flaws in the U.S. patent system Read More
Press Release